HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional) | RFA DA 22 051

Frequently Asked Questions (FAQs)

What is the HEAL Data2Action (D2A) Innovation Projects funding opportunity?

HEAL D2A Innovation Projects (RFA-DA-22-051) is a National Institutes of Health (NIH) grant opportunity, led by the National Institute on Drug Abuse (NIDA), focused on helping communities and service systems use existing data more effectively to prevent and respond to the opioid overdose crisis and to improve care for opioid use disorder (OUD) and pain.

What problem is this program trying to solve?

The program targets a common real-world challenge: valuable data already exist across healthcare, behavioral health, public health, social services, justice systems, and community programs, but those data are often siloed, delayed, or underused. The goal is to synthesize and apply these data in real operating environments so decision-makers can identify risk, spot emerging trends, and act faster.

What is the main goal of an Innovation Project under this announcement?

The main goal is to turn existing data streams into practical tools and decision supports that improve service delivery and enable real-time or near-real-time responsiveness, such as anticipating overdose surges, identifying individuals or communities at elevated risk, improving linkage to treatment and recovery resources, and monitoring whether evidence-based practices are reaching the people who need them.

Which NIH initiative is this opportunity part of?

This opportunity is part of the larger HEAL Initiative and specifically the coordinated HEAL Data2Action (D2A) Program. The D2A Program is designed as a connected network of initiatives rather than isolated standalone projects.

How should applicants think about fit within the broader HEAL D2A Program?

Applicants are expected to understand and describe how their proposed Innovation Project would fit into the broader D2A ecosystem. The overall program is intended to function as a coordinated network with shared supports.

What are the companion initiatives or support centers associated with the HEAL D2A Program?

The NIH released companion funding announcements to provide shared supports for the D2A Program, including a Data Infrastructure Support Center (RFA-DA-22-052), a Research Adoption Support Center (RFA-DA-22-050), and an Economics and Modeling Resource Center (RFA-DA-22-049).

What kinds of outcomes or improvements are these projects expected to support?

Innovation Projects are intended to close gaps in delivery of evidence-based practices and improve how interventions are targeted, implemented, monitored, and adapted in real-world settings. The emphasis is on measurable improvements in service delivery and faster, more proactive responses to changing conditions.

What policy framework or priority areas guide project focus?

Projects are aligned to the four pillars of the HHS Overdose Prevention Strategy: primary prevention, harm reduction, treatment of opioid use disorder, and recovery support.

What does "data to action" mean in the context of this opportunity?

It means using data not just for reporting or retrospective analysis, but to drive operational decisions, workflows, and timely adjustments. The expectation is that data will support prediction and proactive responses rather than relying only on after-the-fact reporting.

What is the grant mechanism used in this funding opportunity?

The award uses a phased R61/R33 mechanism. This generally includes an early, time-limited phase (R61) to establish feasibility and momentum, followed by a subsequent phase (R33) to expand, validate, and more fully implement the approach after predefined milestones are met.

What is the purpose of the R61 phase versus the R33 phase?

The R61 phase is meant to quickly establish feasibility and make early progress. The R33 phase supports broader implementation, validation, and expansion once the project meets predefined milestones. The structure is meant to encourage deliverable, measurable progress.

Are clinical trials required under this announcement?

No. Clinical trials are optional. Applicants may propose clinical trial components if appropriate, but projects are not limited to clinical trial designs and can include other applied or implementation-oriented approaches focused on data-driven action.

What kinds of settings are these Innovation Projects designed for?

Projects are designed for local efforts either within a single system (such as a statewide health system, county public health department, Medicaid program, or hospital network) or through cross-sector partnerships connecting multiple systems and organizations.

What is meant by a "single system" approach?

A single system approach refers to work focused inside one operating entity or system, such as a statewide health system, a county public health department, a Medicaid program, or a hospital network, where data can be organized and used to improve decisions and service delivery.

What is meant by a "cross-sector partnership" approach?

A cross-sector partnership approach refers to collaborations that connect data and action across organizations like healthcare providers, emergency medical services, harm reduction organizations, behavioral health agencies, recovery community organizations, housing services, and justice-related partners.

What types of data sources are relevant to this program?

Relevant data sources may come from healthcare, behavioral health, public health, social services, justice systems, and community programs. The key idea is to use existing data that are currently fragmented or underused and apply them in operational settings.

What does the opportunity emphasize about timeliness of data?

The emphasis is on real-time or near-real-time responsiveness. Projects should strengthen the ability of local systems to act quickly as conditions change, rather than relying solely on delayed or retrospective reporting.

What kinds of deliverables are implied by the program description?

The description points toward practical outputs such as tools, decision supports, coordinated operating approaches, and analytics-to-workflow pathways that inform decisions, change workflows, and support policy or program adjustments as conditions change.

What does it mean for a project to be "grounded in real-world operational constraints"?

It means the project should reflect how service systems actually operate day-to-day, including practical limitations and real implementation environments, and should produce outputs that can realistically be used by decision-makers and practitioners.

Who is eligible to apply for this funding opportunity?

Eligibility is broad and includes many U.S.-based organizations and governmental entities, including state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized) and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; and small businesses.

Are faith-based and community-based organizations eligible?

Yes. The announcement explicitly calls out additional eligible groups such as faith-based or community-based organizations and regional organizations (among others).

Are U.S. territories or possessions eligible to apply?

Yes. U.S. territories or possessions are explicitly called out as eligible.

Are minority-serving institutions eligible to apply?

Yes. The announcement explicitly includes several categories of minority-serving institutions, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs).

Are foreign institutions eligible to apply?

No. Foreign institutions are not eligible to apply.

Can a U.S. organization include a non-U.S. component in its application?

No. Non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them) are not permitted.

Which NIH institute is leading this opportunity?

The opportunity is led by the National Institute on Drug Abuse (NIDA) within NIH.

What is the funding opportunity number?

The funding opportunity number is RFA-DA-22-051.

Is this a discretionary grant opportunity?

Yes. It is described as a discretionary grant opportunity under NIH.

What are the associated CFDA numbers listed for this opportunity?

The CFDA numbers listed are 93.213 and 93.279.

What are the activity areas associated with this opportunity?

The activity areas are tied to education and health.

What are the key dates mentioned in the summary material?

The creation date listed is January 3, 2022, and the original closing date listed is March 10, 2022.

Does the provided summary specify an award ceiling or number of awards?

No. The summary material does not specify an award ceiling or the expected number of awards. It does indicate NIH planned to support multiple Innovation Projects as part of the broader D2A program framework.

What types of applicants are the best fit for this opportunity based on the description?

The strongest fit is for organizations that can demonstrate access to relevant data, strong cross-sector relationships (or a credible plan to build them), and a clear pathway from analytics to action in day-to-day service delivery that measurably improves prevention, harm reduction, OUD treatment, and recovery support.